CASI Pharmaceuticals, Inc.
CASIF· OTC
CASI Pharmaceuticals, Inc.
- Close
- May 15, 2026 · +7.14%
- Market cap
- $3.08M
- 20.56M shares
- Filings
- 157
Price
May 15, 2026 · Official close
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $20,712,000 | reported | |
| FY 2024 | 2024-12-31 | $28,537,000 | reported | |
| FY 2023 | 2023-12-31 | $33,879,000 | reported | |
| FY 2022 | 2022-12-31 | $38,047,000 | reported | |
| FY 2021 | 2021-12-31 | $30,020,000 | reported | |
| FY 2020 | 2020-12-31 | $15,001,000 | reported |
CASI Pharmaceuticals, Inc. · CIK 1962738 · Engraved from SEC EDGAR
